Delivery Order SPE2DE24DA017-SPE2D625F0CTM

Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $8,250 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, for the Arthrex ACP Double Syringe System. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 7, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) with the Defense Logistics Agency, valued at approximately $471 million through September 2029. The award utilizes no set-aside designation, reflecting Arthrex's competitive strength in the federal orthopedic medical device marketplace. Performance will occur at the company's Naples, Florida facility.

This delivery order supports the Department of Defense's medical supply chain operations by providing advanced orthopedic surgical technology. As a Subchapter S Corporation, Arthrex has established itself as a primary supplier of orthopedic implants, surgical instruments, and biologics to government healthcare systems, including the Department of Veterans Affairs and the Department of Defense. The broader IDC enables VA medical centers nationwide to efficiently procure Arthrex's comprehensive portfolio of orthopedic solutions, with delivery orders already exceeding $550,000 to date, demonstrating the company's capability to support specialized healthcare requirements for veterans and military personnel.